发明名称 |
THERAPEUTIC AGENT FOR CEREBRAL INFARCTION |
摘要 |
The present invention provides a novel therapeutic drug for cerebral infarction, which contains a piperazine compound as an active ingredient. The compound of the present invention can be provided as a novel therapeutic drug for cerebral infarction having an effect of suppressing brain injury volume or improving neurological deficit, since it suppresses production of plural inflammatory cytokines and chemokines present in the brain such as TNF-α, IL-1&bgr;, IL-6 and MCP-1 and the like. |
申请公布号 |
US2010179157(A1) |
申请公布日期 |
2010.07.15 |
申请号 |
US20080601609 |
申请日期 |
2008.05.23 |
申请人 |
MITSUBISHI TANABE PHARMA CORPORATION |
发明人 |
NAKAGAWA HARUTO;ANDO NAOKO |
分类号 |
A61K31/495;A61K31/497;A61P9/10;C07D403/14 |
主分类号 |
A61K31/495 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|